Immediate Impact

2 from Science/Nature 73 standout
Sub-graph 1 of 21

Citing Papers

Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade
2024 Standout
Dual-Site Biomimetic Cu/Zn-MOF for Atopic Dermatitis Catalytic Therapy via Suppressing FcγR-Mediated Phagocytosis
2024 Standout
2 intermediate papers

Works of Jonathan Robertson being referenced

Clinical Efficacy and Tolerability of a Novel Selective Corticosteroid in Atopic Dermatitis - Two Randomised Controlled Trials
2015
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
2013

Author Peers

Author Last Decade Papers Cites
Jonathan Robertson 111 15 10 111 68 9 343
Khader Awwad 78 17 4 132 43 19 400
Mohammad A. Tabrizi‐Fard 151 12 1 43 14 12 304
Euan MacIntyre 64 10 9 104 78 10 371
Reginald Jessup 106 9 3 47 48 7 319
Keya Meyers 163 14 52 16 6 387
Takayo Ohto 55 15 2 49 21 8 396
Estel Solsona‐Vilarrasa 79 8 3 29 27 11 373
M. L. Harpin 125 3 2 53 27 15 370
C C Wu 143 37 55 24 9 405
Jicui Chen 95 6 2 109 51 13 353

All Works

Loading papers...

Rankless by CCL
2026